Skip to main content

Table 2 Comparison of laboratory and clinical parameters from active (NOT LTFU) and inactive (LTFU) patients

From: Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania

  Active patients (NOT LTFU) Inactive patients (LTFU exclude those reported dead)  
Median IQR Median IQR Test Statistics
Age 13.00 07.00–19.00 11.00 07.00–15.00 t = 5.696 (p < 0.001)
White blood cell (WBC) (10^3/uL) 13.11 10.69–16.60 13.65 10.90–17.19 t = −0.9953 (0.3197)
Neutrophils (%) 46.50 38.80–54.52 45.20 38.10–53.25 t = 1.9524 (p = 0.0509)
Hemoglobin (g/dL) 07.40 06.60–08.30 07.40 6.70–08.20 t = 0.0620 (p = 0.9505)
Red Blood Cells (RBC) (10^6/uL) 02.85 02.42–03.33 02.83 2.44–3.28 t = 0.1212 (p = 0.9036)
Mean Cell Volume (MCV) (fL) 78.58 72.00–85.20 77.40 71.50–83.80 t = 2.3742 (p = 0.0177)
Mean Cell Hemoglobin Concentration (MCHC)(g/dL) 33.33 31.60–34.90 33.80 32.27–35.10 t = −4.0359 (p < 0.001)
Red Cell Distribution Width (RDW) (%) 22.00 19.70–24.40 22.30 19.80–24.70 t = −0.2216 (p = 0.8247)
Platelets (10^3/uL) 417.00 304.00–522.00 409.50 312–522 t = −0.0655 (p = 0.9478)
Haematocrit (%) 22.22 19.70–22.20 22.80 19.60–24.50 t = 1.5341 (p = 0.1251)
\